Role of the ACMD
The Advisory Committee on Medical Devices (ACMD) is a statutory advisory committee established under the Therapeutic Goods Regulations 1990.
The committee provides independent expert advice on specific scientific and technical matters to support the TGA's decision-making and regulatory processes.
While the advice provided by the ACMD is an important component of the TGA's regulatory functions, it is only part of the information considered by delegates when making decisions under the Therapeutic Goods Act 1989.
It is important to note that while the TGA gives appropriate consideration to ACMD advice, it is not obliged to follow the committee's recommendations.
Additionally, information about the advice provided by the committee may not become publicly available.
The purpose of this meeting statement is to outline, in general terms, the matters considered by the committee at each meeting.
The statement is made publicly available as soon as reasonably practicable after the relevant meeting.
Update
- A liver transplant transport system has been approved.
- A leadless pacemaker system has been approved.
- A knee replacement system has been approved.
- A coronary artery stent has been approved with conditions of inclusion.
No other decisions have been made recently for items previously considered by the committee.
Overview of the medical devices referred for advice
At the 84th ACMD meeting, the committee considered the following devices:
- shoulder prostheses
- a shoulder scaffold
- a knee prosthesis
- an artery scaffold
- a surgical kit for delivering local anaesthetic
- an endovascular, polyester stent
The committee also provided their views on bioprosthetic heart valves.
The committee assessed whether the benefits outweighed the risks for these devices and whether sufficient evidence had been provided to demonstrate their safety and performance, in accordance with the Essential Principles.
Conflict of interest management
Declarations of actual or potential conflicts of interest by committee members are managed by the Chair, committee members, and the Department, both prior to and during meetings, as appropriate.
For meeting #84, one committee member declared that they recently delivered presentations at workshops for a sponsor of competitor products. This represented a real or perceived conflict for this member, and the member was excluded from the discussion on that item.
Another committee member declared that the sponsor of a device being considered by the committee was connected with the member through an industry partner in a company for which the member is a director. This represented a real or perceived conflict for this member, and the member was excluded from the discussion on that item.
Contact
Meeting statements are made publicly available after each meeting.
For more information see Advisory Committee on Medical Devices (ACMD) or contact the ACMD Secretariat by email TGAMedicalDevices@health.gov.au.